Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.

By B. J. Maron, M. Maron, C. Semsarian. 2012

717 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Molecular Biology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. B. Maron
2. Steve R. Ommen
3. M. Maron
4. P. Spirito
5. C. Semsarian
6. Iacopo Olivotto

Citations in the corpus

• New perspectives on the prevalence of hypertrophic cardiomyopathy. (2015, background): “At least 11 genes have now been identified, which primarily encode more than 1,500 cardiac sarcomere and sarcomere-related single-nucleotide mutations, critical for the basic contractile function of the heart (Figure 1) (11,12).”
• Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. (2014, background): “There is no compelling evidence that genetically affected relatives without LVH are at increased risk of SD (12,51,52,56), and Bethesda Conference #36 consensus recommendations do not exclude genotype positivephenotype negative individuals from competitive sports (57).”